Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (ACCD)
NASDAQ:ACCD
Holding ACCD?
Track your performance easily
ACCD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.08 - $15.36
Previous Close$3.8
Volume697.51K
Average Volume (3M)1.28M
Market Cap
$306.04M
Enterprise Value$310.50M
Total Cash (Recent Filing)$234.35M
Total Debt (Recent Filing)$238.81M
Price to Earnings (P/E)―
Beta2.46
Next Earnings
Jan 13, 2025EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.02
Shares Outstanding80,537,080
10 Day Avg. Volume1,261,434
30 Day Avg. Volume1,275,859
Standard Deviation0.22
R-Squared0.19
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.68
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)17.00
P/FCF Ratio22.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.70
Enterprise Value/Gross Profit1.62
Enterprise Value/Ebitda-9.54
Forecast
1Y Price Target
$7.18Price Target Upside88.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Accolade News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company has executed on its plan to manage marketing spend efficiently for usage-based and direct-to-consumer offerings to protect profitability.
Growth And Market PositionACCD's diversified platform, partner ecosystem, and distribution channels should provide some resiliency as customers increasingly focus on managing costs from GLP-1s, cancer, and other items that reflect the complex nature of healthcare benefits.
Pipeline And Business DevelopmentManagement indicated the pipeline remains strong with diversification across employers, health plans, and government segments.
Bears Say
Financial PerformanceThe net cash balance of ~$20MM is likely too small to avoid a follow-on debt offering as its current convertible is due in April 2026.
Market CompetitionFears of increasing pricing pressures were likely stoked by CalPERS choosing a competitor over Accolade in a competitive RFP process.
Revenue GuidanceShares have not recovered from the ~44% decline following the 1Q report when the company revised down FY'25 revenue guidance.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ACCD FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was $3.08 and its highest was $15.36 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Jan 13, 2025 which is in 48 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Oct 08, 2024. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.443 by $0.143.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is -$0.33.
How many shares outstanding does Accolade have?
Accolade has 80,537,080 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.443. Following the earnings report the stock price went up 1.763%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 21M.
---
Accolade Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.18 (88.95% Upside)
$7.18 (88.95% Upside)
Blogger Sentiment
Bullish
ACCD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 289.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.3%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.25%
12-Months-Change
Fundamentals
Return on Equity
-18.61%
Trailing 12-Months
Asset Growth
-11.50%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
ACCD Company Deck
---
ACCD Earnings Call
Q2 2024
0:00 / 0:00
---
ACCD Stock 12 Month Forecast
Average Price Target
$7.18
▲(88.95% Upside)
Technical Analysis
Best Analysts Covering ACCD
1 Year
1 Year Success Rate
5/19 ratings generated profit
1 Year Average Return
-21.69%
reiterated a buy rating 2 months ago
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -21.69% per trade.
---